已传文件：photo/1773121782.png
Introduce injectable cold atmospheric plasma-activated decellularized tumor cell extracellular matrix hydrogel as a postoperative immune activation platform. This genetically engineered gel attracts residual tumor cells and induces immunogenic cell death, reshapes the tumor microenvironment and induces systemic anti-tumor immunity. Combined with checkpoint blockade, it inhibits recurrence and enhances long-term protection after tumor resection. This research was published in Advanced Materials under the title "Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel as a Tumor-Infiltrating Immunoactivation Platform for Post-Surgical Cancer Immunotherapy".
References: DOI: 10.1002/adma.20251544
